Loading
Life sciences · Journal article
Journal of Medicinal Chemistry · October 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Platinum chemotherapy is limited by the thiol reactivity of Pt(II), which promotes interactions with sulfur-containing biomolecules, causing nephrotoxicity and drug deactivation while providing limited efficacy against metastatic disease. Here, we show that direct S,S coordination suppresses Pt(II)-thiol reactivity, mitigating nephrotoxicity while enabling chemo-photodynamic therapy. Three Pt(II) complexes (Pt1−Pt3) containing a dithiolene ligand were designed to pre-satisfy the sulfur affinity of Pt(II). The lead complex, Pt3, resists glutathione binding, exhibits cytotoxicity toward 4T1 triple-negative breast cancer cells (IC50 = 6.05 μM), and shows a 2.6-fold enhancement under 660 nm red-light irradiation (IC50 = 2.29 μM) through singlet oxygen-mediated apoptosis, while remaining minimally toxic to HEK-293 normal kidney cells (IC50 > 100 μM). In an orthotopic 4T1 tumor model, Pt3 demonstrated potent in vivo antitumor activity with reduced nephrotoxicity and suppressed lung metastasis relative to cisplatin and oxaliplatin, establishing direct S,S coordination as a medicinal design strategy for safer Pt(II) chemotherapeutics.